Global Propolis Market Price Trends, Size, Share, Analysis and Forecast 2022-2027

According to the latest report by IMARC Group, titled “Propolis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.' the global propolis market reached a value of US$ 625.5 Million in 2021. Propolis, also known as bee glue, is a resinous mixture produced by honey bees using beeswax, saliva, and exudate gathered from tree buds, sap flows, or other botanical sources. It possesses a pleasant aromatic fragrance and varies in color from yellow-green to dark brown according to age and origin. Moreover, it is widely consumed to strengthen the immune system as it has antioxidant, anesthetic and wound healing properties.



Request for a PDF sample of this report:   https://www.imarcgroup.com/propolis-market/requestsample

The market is primarily driven by the increasing applications of propolis in the health care and personal care sector due to its numerous health benefits, such as improving digestive health, reducing wrinkles, and decreasing cancer risk. In addition, the high fatality of coronavirus disease (COVID-19) is escalating the demand for natural agents with immune-strengthening properties. This is contributing to the market growth as propolis offers antimicrobial, bactericidal, antiviral, anti-inflammatory, and immunomodulatory properties. Furthermore, leading manufacturers are introducing several propolis-based product variants to suit different medical needs. They are also adopting advanced packaging techniques and promotional campaigns to expand their market reach. On account of these factors, the market is expected to create a favorable market outlook across the globe. Looking forward, IMARC Group expects the market to reach US$ 864.1 Million by 2027, exhibiting a CAGR of 5.64% during 2022-2027.

Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape:

·         Apiário Polenectar

·         Apis Flora

·         Bee Health Limited (INW)

·         Comvita Limited

·         Herb Pharm

·         Manuka Health New Zealand

·         Natural Factors Nutritional Products Ltd.

·         NaturaNectar

·         NOW Foods

·         Nutraceutical International Corporation

·         Sunyata Alternative Products Ltd

·         Uniflora Nutraceutica Ltda

·         Wax Green.

Key Market Segmentation:

Breakup by Product Type:

·      Capsules and Tablets

·      Liquids

·      Creams

·      Others
 

Breakup by Category:

·      Alcohol-based

·      Alcohol-free
 

Breakup by Distribution Channel:

·      Supermarkets and Hypermarkets

·      Pharmacies and Drugstores

·      Online Stores

·      Others
 

Breakup by Application:

·      Food and Beverages

·      Healthcare

·      Personal Care and Cosmetics

·      Others

Breakup by Region:

·      North America (United States, Canada)

·      Europe (Germany, France, United Kingdom, Italy, Spain, Others)

·      Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

·      Latin America (Brazil, Mexico, Others)

·      Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:  https://bit.ly/3qLSRXg

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us        

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 


 

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more